Market Tracker

02/24 5:16pm ET

Sanofi SA (NYSE:SNY)

42.70
Delayed Data
As of Feb 24
 +0.19 / +0.45%
Today’s Change
36.81
Today|||52-Week Range
44.50
+5.59%
Year-to-Date
BioMarin Pharmaceutical Inc. Logs a Combined Blockbuster
Feb 25 / MotleyFool.com - Paid Partner Content
Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands?
Feb 19 / MotleyFool.com - Paid Partner Content
BioMarin (BMRN) Q4 Loss Narrower than Expected; Sales Beat
Feb 24 / Zacks.com - Paid Partner Content
Drug Stocks Q4 Earnings Slated for Feb 16: ALXN, ZTS & More
Feb 15 / Zacks.com - Paid Partner Content
Who Could Buy Bristol-Myers Squibb?
Feb 22 / MotleyFool.com - Paid Partner Content
Amgen Looking to Broaden Leukemia Drug Blincyto's Label
Feb 15 / Zacks.com - Paid Partner Content
ImmunoGen, Inc.: Waiting to Move FORWARD
Feb 21 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Morgan Stanley, General Motors, Prudential Financi...
Feb 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close42.51
Today’s open42.27
Day’s range42.26 - 42.84
Volume1,786,466
Average volume (3 months)2,074,165
Market cap$109.9B
Dividend yield3.69%
Data as of 4:02pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+11.60%
Earnings growth (this year)--
Earnings growth (next 5 years)+3.20%
Revenue growth (last year)-2.08%
P/E ratio25.5
Price/Sales2.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.07+0.17%
ABBVAbbVie+0.15+0.24%
BMYBristol-Myers Squibb+0.67+1.20%
AGNAllergan-1.66-0.67%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateApril 28, 2017
EPS forecast (this quarter)$0.66
Annual revenue (last year)$37.3B
Annual profit (last year)$5.2B
Net profit margin12.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts